Evidence map›Paper›PMID 42872842›Full record

ArticleBioethics2026

The Scaleup Costs, Size, and Statistics Challenge to Democratic Deliberation on Health Policy.

Nir Eyal

Abstract read
In one paragraph

Article in Bioethics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Nir EyalGlobal Business School for Health, University College London, London, UK.ORCID https://orcid.org/0000-0003-1056-6609

Funding

Open Philanthripy
6 · The paper itself

Abstract

Current fashion supports aligning health policy with the recommendations of deliberative forums, or mini-publics. These forums' participants are selected randomly from the general public (sometimes with overrepresentation of direct stakeholders or of underrepresented sectors). After being informed and exchanging public reasons with fellow participants under discursive rules that engage all as equals, participants vote on and sometimes rank policy recommendations. According to supporters, a deliberative democratic process that holds such forums and translates their recommendations to policy legitimizes resulting policy. That's thanks to this process's tendencies to strengthen democratic consent, to uncover which policy option is objectively best, to align policy with lay normative outlooks, and to educate the public. I argue that one tri-partite feature of nearly all instances of democratic deliberation on regional, national, and global health policy under current best practice, which I call the "Scaleup costs, Size, and Statistics" ("3S") challenge, largely blocks these alleged welcome tendencies. In particular, barring radical changes, true democratic deliberation is expensive to scale, keeping feasible mini-publics small and irregular. That makes concluding from mini-public recommendations about the population's hypothetical consent, values, and will statistically unreliable. It also caps low mini-publics' contribution to public education. In these ways and in others, the long list of alleged welcome tendencies of proper democratic deliberation on health policy, and the related contribution to political legitimacy, is largely a fiction. Public deliberation does have modest true merit, for example, providing relevant qualitative input about the lay public's occasional factual insights and many endemic errors; and making the public feel "listened to," whether or not it is. But those merits are modest, contingent, and most accentuated under different institutions than envisaged in deliberative democratic literature. Certainly there is room for democratic deliberation, potentially of new breeds, but only as part of the mosaic of health policy design, alongside familiar methods like general elections, public surveys, representative government, and expert decisionmaking. The main question is which method to use when.

Indexed as

Community ParticipationDemocracyHealth PolicyPolicy MakingPoliticsHumansPublic OpinionVoting

Identifiers

PMID42872842
PMCPMC13664653

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.